6920 Little Brook Ct, Elkridge MD 21075, USA

Media

Publications

wooden-blocks
Androgen Receptor Modulation Optimized for Response (ARMOR) Phase I and II Studies: Galeterone for the Treatment of Castration-Resistant Prostate Cancer
Discovery and development of Galeterone (TOK-001 or VN/124-1) for the treatment of all stages of prostate cancer
Large-scale synthesis of galeterone and lead next generation galeterone analog VNPP433-3β
Efficacy of Therapies After Galeterone in Patients With Castration-resistant Prostate Cancer
Galeterone sensitizes breast cancer to chemotherapy via targeting MNK/eIF4E and β-catenin
Galeterone for the treatment of advanced prostate cancer: the evidence to date

Joint Our News Letter

“Get the latest updates on our product development before anyone else.”